Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads. Issue 2 (22nd November 2020)
- Record Type:
- Journal Article
- Title:
- Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads. Issue 2 (22nd November 2020)
- Main Title:
- Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads
- Authors:
- Yang, Li‐Rong
Li, Lin
Meng, Ming‐Yao
Wang, Wen‐Ju
Yang, Song‐Lin
Zhao, Yi‐Yi
Wang, Run‐Qing
Gao, Hui
Tang, Wei‐Wei
Yang, Yang
Yang, Li‐Li
Liao, Li‐Wei
Hou, Zong‐Liu - Abstract:
- Abstract: Adoptive immunotherapy is a new potential method of tumour therapy, among which anti‐CD19 chimeric antigen receptor T‐cell therapy (CAR‐T cell), is a typical treatment agent for haematological malignancies. Previous clinical trials showed that the quality and phenotype of CAR‐T cells expanded ex vivo would seriously affect the tumour treatment efficacy. Although magnetic beads are currently widely used to expand CAR‐T cells, the optimal expansion steps and methods have not been completely established. In this study, the differences between CAR‐T cells expanded with anti‐CD3/CD28 mAb‐coated beads and those expanded with cell‐based aAPCs expressing CD19/CD64/CD86/CD137L/mIL‐15 counter‐receptors were compared. The results showed that the number of CD19‐specific CAR‐T cells with a 4‐1BB and CD28 co‐stimulatory domain was much greater with stimulation by aAPCs than that with beads. In addition, the expression of memory marker CD45RO was higher, whereas expression of exhausted molecules was lower in CAR‐T cells expanded with aAPCs comparing with the beads. Both CAR‐T cells showed significant targeted tumoricidal effects. The CAR‐T cells stimulated with aAPCs secreted apoptosis‐related cytokines. Moreover, they also possessed marked anti‐tumour effect on NAMALWA xenograft mouse model. The present findings provided evidence on the safety and advantage of two expansion methods for CAR‐T cells genetically modified by piggyBac transposon system.
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 25:Issue 2(2021)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 25:Issue 2(2021)
- Issue Display:
- Volume 25, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 25
- Issue:
- 2
- Issue Sort Value:
- 2021-0025-0002-0000
- Page Start:
- 686
- Page End:
- 700
- Publication Date:
- 2020-11-22
- Subjects:
- artificial antigen‐presenting cells -- CAR‐T cells -- CD19 -- piggyBac
Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.16118 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22032.xml